GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Bodisen Biotech Inc (LSE:BODI) » Definitions » Total Current Liabilities

Bodisen Biotech (LSE:BODI) Total Current Liabilities : £0.70 Mil (As of Jun. 2013)


View and export this data going back to . Start your Free Trial

What is Bodisen Biotech Total Current Liabilities?

Total current liabilities includes Accounts Payable & Accrued Expense, Short-Term Debt & Capital Lease Obligation, Other Current Liabilities, and Current Deferred Liabilities. Bodisen Biotech's total current liabilities for the quarter that ended in Jun. 2013 was £0.70


Bodisen Biotech Total Current Liabilities Historical Data

The historical data trend for Bodisen Biotech's Total Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bodisen Biotech Total Current Liabilities Chart

Bodisen Biotech Annual Data
Trend Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12
Total Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.55 0.14 2.36 1.77 1.73

Bodisen Biotech Quarterly Data
Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Jun13
Total Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.70 1.85 2.14 1.73 0.70

Bodisen Biotech Total Current Liabilities Calculation

Total Current Liabilities is the total amount of liabilities that the company needs to pay over the next 12 months.

Bodisen Biotech's Total Current Liabilities for the fiscal year that ended in Dec. 2012 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=0.377+0.883
+Other Current Liabilities+Current Deferred Liabilities
=-0.0010000000000001+0.467
=1.73

Bodisen Biotech's Total Current Liabilities for the quarter that ended in Jun. 2013 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=0.281+0
+Other Current Liabilities+Current Deferred Liabilities
=-0.001+0.417
=0.70

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The increase of Total Current Liabilities of a company is not necessarily a bad thing. This may conserve the company's cash and contribute positively to cash flow.

Total Current Liabilities is linked to Total Current Assets through the Current Ratio and Working Capital. The Current Ratio is equal to dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations. Net working capital is calculated as Total Current Assets minus Total Current Liabilities.


Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term.

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term


Bodisen Biotech Total Current Liabilities Related Terms

Thank you for viewing the detailed overview of Bodisen Biotech's Total Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Bodisen Biotech (LSE:BODI) Business Description

Traded in Other Exchanges
N/A
Address
Bodisen Biotech Inc develops, manufactures and sells organic fertilizers, liquid fertilizers, pesticides and insecticides in China.